Atria Investments Inc Has $1.11 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Atria Investments Inc grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 15.2% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 11,833 shares of the company’s stock after buying an additional 1,565 shares during the period. Atria Investments Inc’s holdings in GE HealthCare Technologies were worth $1,111,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in shares of GE HealthCare Technologies by 9.2% during the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after purchasing an additional 4,107,746 shares in the last quarter. Bank of Montreal Can lifted its stake in GE HealthCare Technologies by 27.5% in the second quarter. Bank of Montreal Can now owns 696,446 shares of the company’s stock valued at $54,964,000 after buying an additional 150,137 shares in the last quarter. Douglas Lane & Associates LLC boosted its holdings in shares of GE HealthCare Technologies by 2.2% in the third quarter. Douglas Lane & Associates LLC now owns 460,004 shares of the company’s stock valued at $43,171,000 after buying an additional 10,099 shares during the period. Canada Pension Plan Investment Board increased its position in shares of GE HealthCare Technologies by 5,075,130.0% during the first quarter. Canada Pension Plan Investment Board now owns 507,523 shares of the company’s stock worth $46,139,000 after acquiring an additional 507,513 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in shares of GE HealthCare Technologies by 1.9% during the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock worth $94,780,000 after acquiring an additional 19,010 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on GEHC shares. Evercore ISI lifted their price target on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research note on Wednesday, September 18th. Wells Fargo & Company upped their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 price target for the company. Finally, Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. One analyst has rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $94.36.

Insider Activity at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares of the company’s stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.27% of the stock is owned by insiders.

GE HealthCare Technologies Stock Down 1.4 %

GEHC stock opened at $81.76 on Friday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The stock has a market capitalization of $37.35 billion, a price-to-earnings ratio of 22.46, a PEG ratio of 3.02 and a beta of 1.24. The business’s fifty day moving average price is $88.70 and its two-hundred day moving average price is $83.48. GE HealthCare Technologies Inc. has a fifty-two week low of $66.39 and a fifty-two week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company’s quarterly revenue was up .9% compared to the same quarter last year. During the same quarter last year, the business earned $0.99 EPS. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date was Friday, October 18th. GE HealthCare Technologies’s payout ratio is currently 3.30%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.